Searched for
BIOLOGICAL E
COVID-19: Government to expedite process of recognition of Biological E Corbevax by other countries"It is necessary to quickly initiate the process of recognition of the Corbevax vaccine and its certificate by other countries while Biolog...29 Apr, 2022, 03.53 PM IST- Biological E asked to give more info on Corbevax for 5-12 year-oldsBiological E had presented interim safety and immunogenicity data of phase 2/3 clinical trials conducted on participants aged 5 to 18 years.14 Apr, 2022, 12.36 AM IST
- Biological E aims to produce 100 mn doses/month of Corbevax from Feb 2022Biological E. Limited plans to complete production at a rate of 75 million doses of its COVID-19 vaccine Corbevax per month, anticipating o...28 Dec, 2021, 03.01 PM IST
- U.S., India's Biological E. finalise $50 mln financing deal for COVID-19 shotsUS & Biological E finalise financing agreement to expand the company's capacity to produce COVID-19 shots.25 Oct, 2021, 03.40 PM IST
- Biological E seeks DCGI's nod for phase-3 trial of Corbevax as booster dose in those vaccinated with Covishield or CovaxinCurrently, phase 2/3 clinical trials of the second indigenously developed Corbevax, an RBD protein sub-unit vaccine to be administered in a...12 Oct, 2021, 06.20 PM IST
- Mansukh Mandaviya holds meeting with Biological-E MD on progress of Covid vaccine Corbevax"Met Ms Mahima Datla, MD of @Biological_E , who briefed me on the progress of their upcoming #COVID19 vaccine, Corbevax. I assured all the ...06 Aug, 2021, 04.27 PM IST
- Biological E signs pact to manufacture Providence vaccineUnder the agreement, Providence will provide the necessary technology transfer for Biological E to manufacture mRNA vaccines in India with ...08 Jul, 2021, 09.57 AM IST
- Centre inks deal with Hyderabad-based Biological-E for second Made-In-India Covid shotThe vaccine, which is currently undergoing phase-3 clinical trials, is likely to be available in the next few months, the health ministry s...03 Jun, 2021, 12.08 PM IST
- India's Biological E. to make Providence Therapeutics' mRNA COVID-19 vaccineProvidence will sell up to 30 million doses of its mRNA vaccine, PTX-COVID19-B, to Biological E., and will also provide the necessary techn...01 Jun, 2021, 05.20 PM IST
- India's Biological E. to produce Johnson & Johnson's COVID-19 vaccineBiological E., based in the southern Indian city of Hyderabad, also plans to produce 75 million to 80 million doses of its own vaccine a mo...18 May, 2021, 10.35 PM IST
- Biological E jabs may hit market by August, says Dr VK PaulAs per the ICMR , Biological E is testing a two-dose vaccine. Similar to Bharat Biotech’s Covaxin, Biological E’s vaccine under trial presc...22 Apr, 2021, 08.04 AM IST
- Biological E may fill global supply gaps of Johnson & Johnson jabsIndia may have to wait for bridging trialJ&J’s deal with Biological E is a global supply agreement and the company will be tapped to meet c...03 Mar, 2021, 07.00 AM IST
- CEPI to invest $5m in Biological E’s projectCEPI has also agreed to an initial contribution of up to $5 million to Hyderabad-based Biological E towards the cost of scaling up the proc...30 Dec, 2020, 08.28 AM IST
- ICMR, Biological E develop purified equine antiserumThe therapy works like plasma therapy. However, the blood plasma is obtained from animals — from horses, in this case — that have recovered...02 Oct, 2020, 07.18 AM IST
- Biological E signs pact with J&J for Covid-19 vaccine technologyBiological E will produce J&J's vaccine at its vaccine production facilities and sell them both in India and export across various global m...13 Aug, 2020, 03.02 PM IST
- Biological E may raise 620 crore via stake saleVaccine company Biological E plans to raise about Rs 620 crore by selling up to 25% stake to financial or strategic investors.01 Oct, 2013, 11.59 AM IST
- Agreement with Biological E to lower cost of vaccine: GAVIGAVI Alliance was created in 2000 to accelerate the introduction of new vaccines so that all children.18 Apr, 2013, 07.07 PM IST
Load More
